Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Additional space for drug research in Saarbrücken, Germany

13.08.2013
Breaking ground for new building at Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) on 21 August

Common press release of the Helmholtz Centre for Infection Research and the Saarland University


A draft of the new HIPS building, which will unite drug researchers under one roof.
Architekten BDA RDS PARTNER

Infection research meets pharmacy: At the HIPS approximately 150 scientists are committed to the search for new drugs. The ground-breaking ceremony on Wednesday, 21 August, marks the beginning of the construction of a new research building. Media representatives are invited to attend the greetings at 10:00 and the breaking ground at approximately 11:00. There will be the possibility for press photos and background discussion.

Prof. Johanna Wanka, the German Federal Minister of Education and Research, and Annegret Kramp-Karrenbauer, the State Prime Minister of Saarland, will attend the ground-breaking ceremony. Also Prof. Jürgen Mlynek, President of the Helmholtz Association, is expected to be present.

Many antibiotics, once celebrated as miracle drugs against infectious diseases, have long lost their potency to the unrelenting rise in antibiotic resistance. As a result, new drugs are desperately needed.

In order to close a gap in drug research, the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, and the Saarland University founded the HIPS in 2009. Almost exactly four years later, the symbolic ground-breaking ceremony on 21 August will be the starting signal for construction of a new HIPS building to begin. On about 4,500 square metres of effective area, three departments and an additional three junior research groups will find new space on the campus of the Saarland University. "So far, our labs are distributed all over the campus," says Prof. Rolf Müller, Managing Director of the HIPS. "In 2015, the new building will be completed, and all staff can then be accommodated under one roof. It will even offer space for new research groups."

The cost, which totals 25 million euros, is funded for a substantial part by the German State of Saarland as well as the European Regional Development Fund. The European Union contribution is aimed at promoting competitiveness in this region. The HIPS’ own share of the cost is 10 %.

“Infection research is the HZI’s focus, whereas traditionally the Saarland University has been strong in pharmaceutical research,” says Prof. Dirk Heinz, the HZI’s scientific director. “The combination with HIPS areas of competence is unprecedented in Germany.” The HIPS is Germany’s first publicly funded non-university-affiliated research institute exclusively dedicated to pharmaceutical research. Scientists are screening natural substances for their therapeutic potential. "Bacteria, fungi and plants produce many highly active metabolites, including antibacterials," explains Müller. When researchers discover an interesting substance, they optimize it for pharmaceutical application using different methods. In addition, HIPS scientists are conducting research into how drugs ultimately arrive at their intended target in the body. To enable drugs to cross biological barriers, they develop drug transporters.

“Saarland University is among the best universities in Germany when it comes to pharmaceutical research. With the new building, novel interesting perspectives will open up for junior researchers,” says Saarland University’s President Prof. Volker Linneweber.

Media representatives are invited to attend the ceremony on the construction site in Stuhlsatzenhausweg. Parking is possible in the car park at Stuhlsatzenhausweg – Entrance Uni Ost. For additional questions, please contact the HZI Public Relations Department at (+49) 531-6181-1401 or by email at: presse@helmholtz-hzi.de.

The Helmholtz Centre for Infection Research (HZI)
Scientists at the Helmholtz Centre for Infection Research in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body’s response to infection. Helping to improve the scientific community’s understanding of a given bacterium’s or virus’ pathogenicity is key to developing effective new treatments and vaccines.

http://www.helmholtz-hzi.de

The Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS)
The Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) is a branch of the Helmholtz Centre for Infection Research (HZI) Braunschweig and was jointly founded in 2009 by the HZI and the University of the Saarland. The researchers are specifically searching for new drugs to fight infectious diseases, optimize them for human use, and conduct research into how they can best be delivered to their target destination in the body.
Saarland University
Saarland University has earned an international reputation for its research in computer science and informatics and for its activities in the life sciences and nanosciences. The university campus in Saarbrücken is home to more than 600 research scientists in the physical sciences and the life sciences, particularly medicine, pharmaceutical science and biology. The university is also distinguished by close ties to France and its strong European focus.

Dr. Birgit Manno | Helmholtz-Zentrum
Further information:
http://www.helmholtz-hzi.de
http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/additional_space_for_drug_research_in_saarbruecken_germany/
http://www.uni-saarland.de

Further reports about: HIPS HZI Infection Saarland infectious disease pharmaceutical research

More articles from Life Sciences:

nachricht Molecular evolution: How the building blocks of life may form in space
26.04.2018 | American Institute of Physics

nachricht Multifunctional bacterial microswimmer able to deliver cargo and destroy itself
26.04.2018 | Max-Planck-Institut für Intelligente Systeme

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Why we need erasable MRI scans

New technology could allow an MRI contrast agent to 'blink off,' helping doctors diagnose disease

Magnetic resonance imaging, or MRI, is a widely used medical tool for taking pictures of the insides of our body. One way to make MRI scans easier to read is...

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

World's smallest optical implantable biodevice

26.04.2018 | Power and Electrical Engineering

Molecular evolution: How the building blocks of life may form in space

26.04.2018 | Life Sciences

First Li-Fi-product with technology from Fraunhofer HHI launched in Japan

26.04.2018 | Power and Electrical Engineering

VideoLinks
Science & Research
Overview of more VideoLinks >>>